Howard G. Welgus insider trades

Open-market stock purchases and sales by Howard G. Welgus, Director at Arcutis Biotherapeutics, Inc, from SEC Form 4 filings since Feb 4, 2020.

Recent trades

DateStockTradeValue
Jun 17, 2026ARQT Arcutis Biotherapeutics, IncSold$16.3K
Jun 15, 2026ARQT Arcutis Biotherapeutics, IncSold$100K
Jun 15, 2026ARQT Arcutis Biotherapeutics, IncBought (not open market)—
Jun 15, 2026ARQT Arcutis Biotherapeutics, IncBought (not open market)—
Jun 15, 2026ARQT Arcutis Biotherapeutics, IncBought (not open market)—
Jun 5, 2026ARQT Arcutis Biotherapeutics, IncBought (not open market)—
Jun 5, 2026ARQT Arcutis Biotherapeutics, IncBought (not open market)—
May 1, 2026ARQT Arcutis Biotherapeutics, IncSold$164K
Apr 1, 2026ARQT Arcutis Biotherapeutics, IncSold$239K
Mar 2, 2026ARQT Arcutis Biotherapeutics, IncSold$257K
Feb 2, 2026ARQT Arcutis Biotherapeutics, IncSold$250K
Jan 2, 2026ARQT Arcutis Biotherapeutics, IncSold$290K
Dec 1, 2025ARQT Arcutis Biotherapeutics, IncSold$302K
Nov 3, 2025ARQT Arcutis Biotherapeutics, IncSold$253K

Companies traded

  • ARQT Arcutis Biotherapeutics, Inc: 73 sales, last Jun 17, 2026

Get free alerts when Howard G. Welgus files a new trade →